Our People

Since its founding in 1984, MOGAM Institute for Biomedical Research has established important milestones that present the direction that Korean life science and new drug development research should take. Now, we are embarking on a new challenge to connect AI and life science based on our long research experience and accumulated scientific achievements. AI is already rapidly changing our daily lives and society as a whole. However, properly utilizing AI in new drug development to lead to actual treatments remains a significant challenge. This is because it requires not only a deep understanding of life phenomena, but also data science capabilities to handle and interpret vast amounts of data, and experience in the actual new drug development process. To this end, MOGAM Institute for Biomedical Research is nurturing researchers with expertise and field experience in various fields, and is devoting all its efforts to successfully connecting AI-based research to new drug development. In particular, we are focusing on research that actually solves problems that have not been solved for a long time in the new drug development process, not just using AI as a simple tool. All members of the institute, including myself, will do our best in AI-based new drug development research so that suffering from diseases can be reduced and more people can enjoy healthy lives. Also, as a non-profit research foundation with the founding philosophy of contributing to society, we will become an open research arena where academia, hospitals, and industry can naturally connect to create greater change. We will do our best to ensure that the research of MOGAM Institute for Biomedical Research extends beyond the laboratory to the health and future of society as a whole.